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Eosinophils play crucial roles in the tissue inflam-
matory reactions associated with tissue-invasive
helminth infections, as well as allergic diseases
(Gleich and Adolphson, 1996; Kita et al., 1998). During
these inflammatory reactions, eosinophils are stimu-
lated by the appropriate stimuli, which include secre-
tory immunoglobulin A (IgA) (Abu-Ghazaleh et al.,
1989), platelet-activating factor (PAF) (Kroegel et al.,
1989), complement fragments (e. g., C5a) (Zeck-Kapp
et al., 1995), and cytokines (e. g., IL-5, IL-3, and GM-
CSF) (Horie et al., 1996). The activated eosinophils
release toxic oxygen metabolites and cytotoxic granu-
lar proteins, which may contribute to the pathogenesis
of eosinophil-mediated tissue inflammation.
However, the pathophysiological stimuli involved in
the regulation of the eosinophilic effector functions
remain largely unknown. 
Paragonimus westermani is a tissue-invasive parasite,
which causes either pulmonary or extrapulmonary
paragonimiasis in humans. The excretory-secretory
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Abstract: Eosinophil degranulation is considered to be a key effector function for the killing of helminthic worms
and tissue inflammation at worm-infected lesion sites. However, relatively little data are available with regard to
eosinophil response after stimulation with worm-secreted products which contain a large quantity of cysteine proteas-
es. In this study, we attempted to determine whether the degranulation of human eosinophils could be induced by the
direct stimulation of the excretory-secretory products (ESP) of Paragonimus westermani, which causes pulmonary
paragonimiasis in human beings. Incubation of eosinophils for 3 hr with Paragonimus-secreted products resulted in
marked degranulation, as evidenced by the release of eosinophil-derived neurotoxin (EDN) in the culture super-
natants. Moreover, superoxide anion was produced by eosinophils after stimulation of the ESP. The ESP-induced
EDN release was found to be significantly inhibited when the ESP was pretreated with protease inhibitor cocktail or
the cysteine protease inhibitor, E-64. These findings suggest that human eosinophils become degranulated in
response to P. westermani-secreted proteases, which may contribute to in vivo tissue inflammation around the
worms.
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products (ESP) produced by P. westermani newly
excysted metacercariae (PwNEM), which harbor a
prodigious amount of cysteine proteases (Chung et
al., 1995; Shin and Lee, 2000), play key roles in larval
migration in host tissues, and exert modulatory effects
on host immune responses (Chung et al., 1995; Chung
et al., 1997a, 1997b; Shin and Lee, 2000; Shin et al.,
2001). However, the precise roles of the parasite-
secreted proteases with regard to the functions of the
eosinophils have, thus far, remained enigmatic,
although the potential roles of proteases derived from
mites (King et al., 1998), fungi (kauffman et al., 2000),
and bacteria (Lourbakos et al., 2001a, 2001b) in inflam-
matory responses have been reported in previous
studies. Therefore, we have attempted to investigate
the regulatory role of cysteine protease in the ESP
secreted by PwNEM in effector functions of human
eosinophils. 
The ESP was generated from 5,000 PwNEM, as pre-
viously described (Shin et al., 2001). The protease
activity of the ESP checked by a casein protease assay,
using the QuantiCleaveTM protease assay kit (Pierce,
Rockford, IL, USA). In addition, we measured relative
protease activity of the ESP using synthetic dipeptide
substrate carbobenzoyl-phenylalanyl-arginyl-7-
amino-4-methylcoumarin (Cbz-Phe-Arg-AMC)
(Sigma, St. Louis, MO, USA) with 2 mM dithioreitol
(DTT). One unit of the enzyme activity was deter-
mined as the amount of the enzyme that caused
releasing of 1 µM of AMC in 1 hr. The enzyme inhibi-
tion test was measured with various classes of pro-
tease inhibitors such as iodoacetic acid (IAA, 20 µM),
trans epoxy-succinly-L-leucyl-amido(4-guanidino)
butane (E-64, 10 µM), di-isopropylfluorophosphate
(DFP, 2 mM), 4-(amidinophenyl) methanesulphonyl
fluoride (APMSF, 10 µM), L-1-chloro-3-[4-tosylami-
do]-7-amino-2-heptanone · HCl, tosyl lysyl chlorome-
thyl ketone (TLCK 0.1 mM), 1,10-Phenanthroline (2
mM). As shown in Table 1, cysteine protease
inhibitors such as IAA and E-64, almost completely
inhibited protease activity of the ESP compared to
that of non-treated ESP. However, serine protease
inhibitors such as DFP and APMSF or a metallopro-
tease inhibitor (1,10-phenanthroline) did not inhibit
the protease activity of the ESP. 
Human peripheral blood was collected from normal
volunteers without no medication of allergic drugs,
and eosinophils were isolated by immunomagnetic
negative selection, using anti-human CD16 conjugat-
ed with magnetic beads (Miltenyi Biotec, Bergisch
Gladbach, Germany), as previously described (Shin et
al., 2001). The purity of the eosinophils was consis-
tently greater than 95%, as determined by Randolph’s
staining. Superoxide production was measured by
determining the superoxide dismutase-inhibitable
reduction of cytochrome c, as reported in a previous
work (Shin et al., 2001). In order to quantify the
degree of eosinophil degranulation, we measured the
concentrations of eosinophil-derived neurotoxin
(EDN) in the culture supernatants by specific RIA, as
previously described (Shin et al., 2001). In addition, in
order to determine the role of the cysteine proteolytic
activity of the ESP produced by PwNEM in eosinophil
degranulation, the ESP (100 µg/ml) was preincubated
with or without a protease inhibitor cocktail
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Table 1. Relative protease activities of metacercarial ESP
secreted by PwNEM by treatment with various protease
inhibitorsa)
Inhibitors Relative activity (%)
Control (without inhibitor) 100
IAA 4.7
E-64 1.8
DFP 105.1
APMSF 102.0
TLCK 4.9
1,10-phenanthroline 93.0
a)Proteolytic assay was measured fluorometrically using
synthetic dipeptide substrate Cbz-Phe-Arg-AMC with 2
mM DTT. One unit of the enzyme activity was determined
as the amount of the enzyme that caused releasing of 1 µM
of AMC in 1 hr. The enzyme inhibition test was measured
with specific protease inhibitors such as iodoacetic acid
(IAA, 20 µM), trans epoxy-succinly-L-leucyl-amido(4-
guanidino) butane (E-64, 10 µM), di-isopropylfluorophos-
phate (DFP, 2 mM), 4-(amidinophenyl) methanesulphonyl
fluoride (APMSF, 10 µM), L-1-chloro-3-[4-tosylamido]-7-
amino-2-heptanone · HCl, tosyl lysyl chloromethyl ketone
(TLCK 0.1 mM), 1,10-Phenanthroline (2 mM). Data are
presented as average of two separate experiments.
(Boeringer Manheim Biochemicals, Germany) or the
cysteine protease inhibitor, E-64  (EMD Biosciences,
San Diego, CA, USA) at RT for 50 min before incuba-
tion with the eosinophils. Data were expressed as
mean ± SEM from three independent experiments
with different donors. The statistical significance of
the differences between the treatment and control
groups was assessed by Student’s t test. Probability
values of less than 0.05 were considered to be signifi-
cant. 
Eosinophils incubated with different concentrations
(10, 30, and 100 µg/ml) of ESP exhibited superoxide
anion production in a time and concentration-depen-
dent manner (Fig. 1A). After 3 hr of incubation, when
the eosinophils were stimulated with 100 µg/ml ESP,
18.1 ± 1.53 nmole of superoxide were produced. This
value represents approximately 70% of the superoxide
produced by the cells incubated with 1 µM platelet
Shin et al.: Eosinophil degranulation by Paragonimus westermani 35
Fig. 1. Superoxide anion production (A) and degranula-
tion (B) by human eosinophils stimulated with ESP pro-
duced by PwNEM. Eosinophils were stimulated with
three different concentrations (10, 30 and 100 µg/ml) of
ESP, PAF (1 µM), or medium alone, for up to 3 hr at 37°C.
Superoxide production was then measured by determin-
ing the superoxide dismutase-inhibitable reduction of
cytochrome c. After 3 hr of incubation, the concentrations
of EDN in the cell-free supernatants were measured by
RIA, as an index of eosinophil degranulation. Data are
expressed as means ± SEM from three independent exper-
iments with different eosinophil donors. *, denotes signifi-
cant differences (P < 0.05) as compared with the medium
alone.
Fig. 2. Effects of protease inhibitor (PI) cocktail or cysteine
protease inhibitor (E-64) on the ESP-induced eosinophil
degranulation. The ESP by PwNEM (100 µg/ml) or PAF (1
µM) were preincubated with or without protease inhibitor
cocktail solution (3 µl) or E-64 (final conc., 10 µM) for 50
min at RT, and eosinophils were stimulated with the pre-
treated samples for 3 hr at 37°C. Degranulation was mea-
sured as described in Fig. 1. The data were normalized to
the values of the stimulus alone, without protease
inhibitor cocktail or E-64. This value was considered 100%.
Protease inhibitor cocktail or E-64 at the indicated concen-
trations in this experiment did not show any degranula-
tive effect on eosinophils. Data are presented as means ±
SEM of three independent experiments with different
eosinophil donors. *, denotes significant differences (P <
0.05) compared with ESP without protease inhibitor cock-
tail or E-64.
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activating factor (PAF). However, little or no produc-
tion of superoxide was observed when the cells were
stimulated with 10 µg/ml ESP or medium alone.
Furthermore, as shown in Figure 1B, we found that
the ESP strongly induced eosinophil degranulation, as
measured by EDN release, in a concentration-depen-
dent manner. At 30 and 100 µg/ml, the ESP induced
170.4 ± 26.3 and 640 ± 122.8 ng release of EDN/106
cells, respectively. The amount of EDN release
induced by 100 µg of ESP/ml was 2.3 times as high as
that which was induced by 1 µM PAF (280 ± 91.6
ng/106 cells). In contrast, the amounts of EDN release
induced by stimulation of 10 µg/ml ESP and medium
alone were 58.4 ± 1.4 and 35.2 ± 4.9 ng/106 cells,
respectively. These findings suggest that the ESP pro-
duced by PwNEM stimulates human eosinophils to
induce superoxide production and degranulation. In
order to determine whether the ability of the ESP pro-
duced by PwNEM to induce eosinophil degranulation
might be attributable to the proteolytic activity of cys-
teine proteases in the ESP, we assessed the inhibitory
effects of either a protease inhibitor cocktail or E-64 on
the eosinophil degranulation induced by 100 µg of
ESP/ml. As shown in Fig. 2, when the ESP was pre-
treated with the protease inhibitor cocktail, ESP-
induced EDN release was significantly inhibited by
47% (P < 0.05) compared to non-treated ESP.
Similarly, pretreatment with E-64 also resulted in the
significant inhibition of ESP-induced eosinophil
degranulation by 46% (P < 0.05). By contrast, PAF-
induced eosinophil degranulation was not found to be
affected by pretreatment of the PAF with protease
inhibitor cocktail (mean inhibition, 1.6%). These
results suggest that cysteine proteolytic activity plays
a major role in the activation of eosinophils, and func-
tions as a response to the ESP which is produced by
the PwNEM. Although we were unable to exclude the
possibility that other components in the ESP might be
involved in the degranulation of the eosinophils, our
finding that the regulation of eosinophil’s effector
functions induced by the ESP produced by PwNEN
might constitute an important clue toward our under-
standing of the pathophysiological roles of worm-
secreted cysteine proteases with regard to eosinophilic
inflammation at worm-infected lesion sites (Racz et
al., 1982). Recently, the proteolytic activity of cysteine
or serine protease derived from oral pathogens and
mite allergens has been demonstrated to exert regula-
tory effects on the behavior of human cells through a
family of G protein-coupled protease-activated recep-
tors (PARs) (Lourbakos et al., 2001a, 2001b; Sun et al.,
2001; Asokananthan et al., 2002). The cleavage of the
extracellular NH2-domains of these receptors via the
proteolytic actions of extracellular protease exposes a
specific new-NH2 terminus, which is composed of six
or more amino acids, which act as tethered ligands,
and activate the seven-transmembrane domains of the
cleaved receptor (Dery et al., 1998; Macfarlane, 2001).
Thus, cells bearing PARs detect different extracellular
protease concentrations according to the rate at which
receptor cleavage proceeds (Ishii et al., 1993).
Moreover, human eosinophils can be activated by ser-
ine protease trypsin or cysteine proteases such as
papain via PAR2, and thereby induce the production
of the superoxide anion, as well as eosinophilic
degranulation (Miike et al., 2001; Miike and Kita,
2003). Thus, it has been hypothesized that the
eosinophil’s responses, as induced by Paragonimus-
secreted cysteine protease, may be transmitted
through PAR-driven mechanisms. This warrants fur-
ther inquiry into the signaling interactions occurring
between the worm-secreted cysteine protease and the
PARs in eosinophils.
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